Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.
about
Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detectionDNA studies using atomic force microscopy: capabilities for measurement of short DNA fragmentsEGFR-TKI resistance in NSCLC patients: mechanisms and strategiesOrigins, structures, and functions of circulating DNA in oncologyMonitoring the dynamics of clonal tumour evolution in vivo using secreted luciferasesLengthening and shortening of plasma DNA in hepatocellular carcinoma patients.Digital detection of multiple minority mutants and expression levels of multiple colorectal cancer-related genes using digital-PCR coupled with bead-arrayEPMA position paper in cancer: current overview and future perspectives.Comparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancerCirculating Cell-Free Tumour DNA in the Management of Cancer.SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients.Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.Determinants of recurrence after intended curative resection for colorectal cancer.Neutrophil extracellular traps: a walk on the wild side of exercise immunology.Role of Circulating Cell-Free DNA in Cancers.The role of cell-free DNA in predicting colorectal cancer prognosis.Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.Kinetic analysis, size profiling, and bioenergetic association of DNA released by selected cell lines in vitro.Clinical Applications of Liquid Biopsies in Gastrointestinal Oncology.KRAS mutation screening by chip-based DNA hybridization--a further step towards personalized oncology.Role of circulating free DNA in colorectal cancer.Liquid biopsies come of age: towards implementation of circulating tumour DNA.Integrating liquid biopsies into the management of cancer.Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastasesUsing circulating cell-free DNA to monitor personalized cancer therapy.Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancerThe detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC.Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring.Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms.Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of KRAS mutations using Intplex allele-specific PCR.Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer.Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System?Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis.Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.Computational optimisation of targeted DNA sequencing for cancer detection.Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction
P2860
Q26991998-DA68D943-64C0-43A2-847C-376647FCF944Q28080979-2DD21180-3C63-4B8C-AFB2-FAF6859DAEF5Q28394310-F93B2ECB-F2C4-45AE-BF51-E53A7FAFFE5FQ30249103-7FFC26B7-6F70-409F-BF29-60A1FD35665DQ33764406-90792B12-4DCA-4409-B3CE-62CB99BACAC8Q35212779-CAB7E32C-829A-47F3-B57A-85B7842853D7Q35447750-32DD53A2-46ED-40E5-961A-7ADEA6924718Q35532215-FF39A170-30A9-4577-9AC1-46B524E9A48DQ35576801-DDBA2F78-B282-4598-B985-30B3D1417F19Q35814162-CB3FDFD6-7E23-433A-9CC9-14C94EA048FDQ35839745-876497AB-EE21-4362-9FFA-13A47CE49DA7Q35877954-669CBDF3-F705-4D69-9170-595F39B1CFD4Q37225239-0B567463-7C47-4DFA-B514-085E8B21EA8BQ38265049-1FD96F2A-35D3-497E-84B6-99A914AFFCBFQ38287683-8C819A0B-0C84-4E75-A68D-24B492227C40Q38591963-DB1EF582-7114-4F9D-83AC-5D3E9E99C54AQ38637642-08847FB1-7C4E-488F-8A5B-42E18054CC33Q38699032-CAA716B7-190C-433E-B028-FEA648FD32B7Q38711643-6BC19E67-B30A-4DA1-8884-289C998B7955Q38800475-B373B4F5-761A-417D-A3EB-399D6DD76065Q38906896-CB207F3B-AA45-45C5-8318-4503D8A26CCAQ39051652-57609645-E573-4371-8F85-02F6CEA1F998Q39149201-8C220D98-5282-4C2B-8A55-62B4914B70FEQ39157824-EBE0A539-1E16-43D5-BF8F-D8FDB4A693C7Q40431521-EACFF7AE-3041-4309-AC80-1FD070F98BCFQ40460053-FCEA178D-171B-4E82-8C26-525CB1A68108Q41134871-C11118A5-9B3B-4ED1-A65E-D83603AFB834Q41472736-4D9C6C3F-53F5-4A57-A6EC-D925DD3FCAD6Q42687570-A327AF3F-222B-4564-9A04-C2D57872A6DCQ43337595-8DF63A72-2C1B-4EDD-BF2E-A789A71E1A0DQ43646628-4EAA04B5-8319-4AA6-BB7D-C5ACECCFEFADQ45989066-50259BB5-C79E-478F-BD8E-7C6C180776ABQ47563363-2A43A936-5E73-453C-B9E5-DAEA0F1CD412Q47984460-88ABF8E3-2E7B-44E0-AE69-E544BCC3F97EQ48178985-4F03321D-764E-4DB9-8E4E-3491160D71E3Q48277300-CF41E402-6E7F-41B1-9F8C-95AE95B73358Q49502117-92858204-84A0-4348-B412-C68622136F94Q50036937-3916D990-CCCF-40AC-99DD-9BAA74E9964AQ53080459-E6744947-2BE0-44EF-ABAC-7200ABBFCB20Q57170570-1DA30332-F26B-472C-B235-56F1192E9F41
P2860
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Circulating Cell-Free DNA from ...... gh KRAS or BRAF Mutation Load.
@en
type
label
Circulating Cell-Free DNA from ...... gh KRAS or BRAF Mutation Load.
@en
prefLabel
Circulating Cell-Free DNA from ...... gh KRAS or BRAF Mutation Load.
@en
P2093
P2860
P50
P356
P1476
Circulating Cell-Free DNA from ...... igh KRAS or BRAF Mutation Load
@en
P2093
Alain R Thierry
Anne-Sophie Guedj
Bruno Robert
Celine Gongora
Denis Pezet
Evelyne Lopez-Crapez
Franck Molina
Maguy Del Rio
Safia El Messaoudi
P2860
P304
P356
10.1593/TLO.12445
P577
2013-06-01T00:00:00Z